Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05973838 · ClinicalTrials.gov registry record · NA
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
A NA study of Substance-Related Disorders and Treatment Adherence, sponsored by University of Maryland, College Park.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 4
- Study locations
NCT05973838 is a NA study of Substance-Related Disorders and Treatment Adherence that is actively recruiting participants, run by University of Maryland, College Park. The registered enrollment target is 180 participants, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (88% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT05973838, a NA study of Substance-Related Disorders and Treatment Adherence, is actively recruiting participants, sponsored by University of Maryland, College Park.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved areas. The intervention is based on behavioral activation (BA) and is specifically designed to be implemented by a trained peer recovery specialist. In this hybrid, Type-1 effectiveness-implementation randomized controlled trial (RCT), the investigators will evaluate the effectiveness and implementation of Peer Activate vs. treatment as usual (TAU) over twelve months.
Conditions Studied
Interventions
- BEHAVIORAL Peer-Delivered Behavioral Activation ("Peer Activate")
Study Locations (4)
Maryland
- University of Maryland Baltimore (UMD Drug Treatment Center) - Baltimore
- University of Maryland, College Park - College Park
- Caroline County Behavioral Health - Denton
District of Columbia
- HIPS Clinic - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2023-06-15 |
| Est. Completion | 2027-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05973838
The ClinicalTrials.gov registry entry for NCT05973838 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,518-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (88% lower). The listed sponsor is University of Maryland, College Park, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Peer-Delivered Behavioral Activation ("Peer Activate") is the first listed.
NCT05973838 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Maryland, District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05973838 about?
NCT05973838 is a clinical study titled "Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention". The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder (MOUD) and reduce polysubstance use among patients with OUD and polysubstance use in underserved areas. The intervention...
What is the current status of trial NCT05973838?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-06-15. Estimated completion is 2027-09-01.
What conditions does trial NCT05973838 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Treatment Adherence, Retention in Care, Opioid Medication Assisted Treatment, Polysubstance Addiction.
What interventions are being tested in trial NCT05973838?
The interventions under investigation include: Peer-Delivered Behavioral Activation ("Peer Activate") (BEHAVIORAL).
Who is sponsoring clinical trial NCT05973838?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05973838 being conducted?
This trial has 4 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase II: Scalable Digital Delivery of CRAFT Training for Professionals to Maximize Treatment Rates of OUD in Families
RECRUITING · NA
-
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents in Rural Regions
RECRUITING · NA
-
Feasibility of the 5-Step Method in the U.S.
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
-
Expression of Stress Markers During Meth Treatment (EXPRESS+)
RECRUITING · NA
-
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
RECRUITING · NA
Explore more on PlainTrial
Substance-Related Disorders
All registered trials for this condition
Treatment Adherence
All registered trials for this condition
District of Columbia
All trials with a study site in District of Columbia
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.